O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents
申请人:Roche Diagnostics GmbH
公开号:EP1026165A1
公开(公告)日:2000-08-09
New compounds of formula I
wherein:
R and R1 are independently selected from hydrogen, (C1-C6)alkyl, styryl and (C3-C6)cycloalkyl or, taken together with the carbon to which they are linked, form a (C3-C6)cycloalkyl group;
A is selected from the following groups:
wherein q is an integer from 2 to 3
B is selected from
T is selected from -CH2-C≡CH, -C≡CH, -(CH2)p-R3, -CH=CH-R3, -CH2-NHCO-R3, -(CH2)p-O-R3, -CH(NH2)-CH2R3, in which p is 0 or an integer from 1 to 4,
R3 is a carbocyclic or heterocyclic ring as medicaments having antitumor and/or antimetastatic activities.
式 I 的新化合物
其中
R 和 R1 独立选自氢、(C1-C6)烷基、苯乙烯基和(C3-C6)环烷基,或与它们连接的碳一起形成 (C3-C6) 环烷基;
A 选自以下基团:
其中 q 为 2 至 3 的整数
B 选自
T 选自-CH2-C≡CH、-C≡CH、-(CH2)p-R3、-CH=CH-R3、-CH2-NHCO-R3、-(CH2)p-O-R3、-CH(NH2)-CH2R3,其中 p 为 0 或 1 至 4 的整数、
R3 是碳环或杂环,作为具有抗肿瘤和/或抗肿瘤活性的药物。